Content:
This guideline covers FIH/early CTs including those which generate initial knowledge in humans on tolerability, safety, PK and PD. These trials may also include collection of data on e.g. food or drug interactions, different age groups or gender, proof of concept and relative bioavailability of different formulations. These trials are often undertaken in healthy volunteers but can also include patients.